1. Home
  2. XOMAO
  3. XOMAO News

Latest AGNC Investment Corp. (XOMAO) News on June 1, 2025

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
XOMAO

GlobeNewswire

5 days ago

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
XOMAO

Simply Wall St.

16 days ago

Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

XOMA Royalty First Quarter 2025 Earnings: Beats Expectations
XOMAO

Simply Wall St.

17 days ago

XOMA Royalty First Quarter 2025 Earnings: Beats Expectations

XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates
XOMAO

Zacks

19 days ago

XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates

XOMAO

Associated Press Finance

19 days ago

XOMA Royalty: Q1 Earnings Snapshot

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
XOMAO

GlobeNewswire

19 days ago

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
XOMAO

GlobeNewswire

25 days ago

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference

High Growth Tech Stocks In The US To Watch April 2025
XOMAO

Simply Wall St.

a month ago

High Growth Tech Stocks In The US To Watch April 2025

XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability
XOMAO

Simply Wall St.

2 months ago

XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability

XOMA Royalty Completes Sale of Kinnate Pipeline Assets
XOMAO

GlobeNewswire

2 months ago

XOMA Royalty Completes Sale of Kinnate Pipeline Assets

XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout
XOMAO

Insider Monkey

2 months ago

XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout

XOMAO

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 04/09/2025

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
XOMAO

GlobeNewswire

2 months ago

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMAO

GlobeNewswire

2 months ago

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Full Year 2024 Earnings: EPS Misses Expectations
XOMAO

Simply Wall St.

2 months ago

XOMA Royalty Full Year 2024 Earnings: EPS Misses Expectations

XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements
XOMAO

GlobeNewswire

2 months ago

XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements

XOMA Royalty Corporation's (NASDAQ:XOMA) largest shareholders are retail investors with 38% ownership, institutions own 36%
XOMAO

Simply Wall St.

3 months ago

XOMA Royalty Corporation's (NASDAQ:XOMA) largest shareholders are retail investors with 38% ownership, institutions own 36%

XOMA Royalty to Present at Investor Conferences in March
XOMAO

GlobeNewswire

3 months ago

XOMA Royalty to Present at Investor Conferences in March

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
XOMAO

GlobeNewswire

4 months ago

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

XOMAO

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 01/29/2025

XOMAO

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 01/06/2025

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMAO

GlobeNewswire

5 months ago

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMAO

MT Newswires

6 months ago

XOMA Royalty Acquires Pulmokine for $20 Million

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
XOMAO

GlobeNewswire

6 months ago

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

What Makes XOMA Royalty (XOMA) a New Buy Stock
XOMAO

Zacks

7 months ago

What Makes XOMA Royalty (XOMA) a New Buy Stock

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
XOMAO

Simply Wall St.

7 months ago

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
XOMAO

Simply Wall St.

7 months ago

XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates
XOMAO

Zacks

7 months ago

XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates

XOMAO

Associated Press Finance

7 months ago

XOMA Royalty: Q3 Earnings Snapshot

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
XOMAO

GlobeNewswire

7 months ago

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
XOMAO

GlobeNewswire

7 months ago

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year
XOMAO

Simply Wall St.

7 months ago

Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
XOMAO

GlobeNewswire

8 months ago

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMAO

GlobeNewswire

8 months ago

XOMA Royalty Declares Quarterly Preferred Stock Dividends

High Growth Tech Stocks In The United States To Watch
XOMAO

Simply Wall St.

9 months ago

High Growth Tech Stocks In The United States To Watch

XOMA Royalty to Present at Upcoming Investor Conferences in September
XOMAO

GlobeNewswire

9 months ago

XOMA Royalty to Present at Upcoming Investor Conferences in September

Party Time: Brokers Just Made Major Increases To Their XOMA Royalty Corporation (NASDAQ:XOMA) Earnings Forecasts
XOMAO

Simply Wall St.

9 months ago

Party Time: Brokers Just Made Major Increases To Their XOMA Royalty Corporation (NASDAQ:XOMA) Earnings Forecasts

XOMA Royalty Second Quarter 2024 Earnings: Beats Expectations
XOMAO

Simply Wall St.

10 months ago

XOMA Royalty Second Quarter 2024 Earnings: Beats Expectations

XOMA Royalty (XOMA) Reports Q2 Loss, Tops Revenue Estimates
XOMAO

Zacks

10 months ago

XOMA Royalty (XOMA) Reports Q2 Loss, Tops Revenue Estimates

XOMAO

Associated Press Finance

10 months ago

XOMA Royalty: Q2 Earnings Snapshot

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
XOMAO

GlobeNewswire

10 months ago

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

ITeos Therapeutics, Inc. (ITOS) Reports Q2 Loss, Tops Revenue Estimates
XOMAO

Zacks

10 months ago

ITeos Therapeutics, Inc. (ITOS) Reports Q2 Loss, Tops Revenue Estimates

Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?
XOMAO

Zacks

10 months ago

Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?

XOMA Corporation's (NASDAQ:XOMA) institutional investors lost 11% last week but have benefitted from longer-term gains
XOMAO

Simply Wall St.

a year ago

XOMA Corporation's (NASDAQ:XOMA) institutional investors lost 11% last week but have benefitted from longer-term gains

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?
XOMAO

Zacks

a year ago

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?

XOMA Declares Quarterly Preferred Stock Dividends
XOMAO

GlobeNewswire

a year ago

XOMA Declares Quarterly Preferred Stock Dividends

XOMAO

MT Newswires

a year ago

XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
XOMAO

GlobeNewswire

a year ago

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher

XOMAO

Business Wire

a year ago

Net Asset Value(s)

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
XOMAO

GlobeNewswire

a year ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence
XOMAO

Business Wire

a year ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Dstny honored with 'Employee Wellbeing Award'
XOMAO

PR Newswire

a year ago

Dstny honored with 'Employee Wellbeing Award'

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities
XOMAO

Business Wire

a year ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon
XOMAO

Newsfile

a year ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024
XOMAO

PR Newswire

a year ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%
XOMAO

GlobeNewswire

a year ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
XOMAO

GlobeNewswire

a year ago

XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ

XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss
XOMAO

GuruFocus.com

a year ago

XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss

XOMAO

Associated Press Finance

a year ago

Xoma: Q1 Earnings Snapshot

XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
XOMAO

GlobeNewswire

a year ago

XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities

Certara, Inc. (CERT) Q1 Earnings Meet Estimates
XOMAO

Zacks

a year ago

Certara, Inc. (CERT) Q1 Earnings Meet Estimates

Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
XOMAO

Zacks

a year ago

Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
XOMAO

GlobeNewswire

a year ago

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
XOMAO

GlobeNewswire

a year ago

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)

Actym Therapeutics Appoints Thomas Smart as CEO
XOMAO

PR Newswire

a year ago

Actym Therapeutics Appoints Thomas Smart as CEO

XOMA (NASDAQ:XOMA) shareholders have earned a 16% CAGR over the last five years
XOMAO

Simply Wall St.

a year ago

XOMA (NASDAQ:XOMA) shareholders have earned a 16% CAGR over the last five years

XOMA Corporation Announces Closing of Tender Offer
XOMAO

GlobeNewswire

a year ago

XOMA Corporation Announces Closing of Tender Offer

XOMA Declares Quarterly Preferred Stock Dividends
XOMAO

GlobeNewswire

a year ago

XOMA Declares Quarterly Preferred Stock Dividends

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
XOMAO

GlobeNewswire

a year ago

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.

XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023
XOMAO

GuruFocus.com

a year ago

XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023

XOMAO

Associated Press Finance

a year ago

Xoma: Q4 Earnings Snapshot

XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
XOMAO

GlobeNewswire

a year ago

XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value

XOMA to Present at Upcoming Investor Conferences in March
XOMAO

GlobeNewswire

a year ago

XOMA to Present at Upcoming Investor Conferences in March

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
XOMAO

GlobeNewswire

a year ago

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right

FaZe Clan and Rollbit Announce Multi-Million Dollar Esports Sponsorship Deal
XOMAO

ACCESSWIRE

a year ago

FaZe Clan and Rollbit Announce Multi-Million Dollar Esports Sponsorship Deal

With 37% ownership, XOMA Corporation (NASDAQ:XOMA) has piqued the interest of institutional investors
XOMAO

Simply Wall St.

a year ago

With 37% ownership, XOMA Corporation (NASDAQ:XOMA) has piqued the interest of institutional investors

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition
XOMAO

GlobeNewswire

a year ago

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone
XOMAO

Business Wire

a year ago

Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone

Prairie Operating Announces Acquisition of Producing E&P Assets
XOMAO

GlobeNewswire

a year ago

Prairie Operating Announces Acquisition of Producing E&P Assets

FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
XOMAO

GlobeNewswire

a year ago

FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx

XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors
XOMAO

GlobeNewswire

a year ago

XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Announces Stock Repurchase Program of up to $50 Million
XOMAO

GlobeNewswire

a year ago

XOMA Announces Stock Repurchase Program of up to $50 Million

Biodexa Appoints Ann Merchant to the Board of Directors
XOMAO

GlobeNewswire

a year ago

Biodexa Appoints Ann Merchant to the Board of Directors

Foremost Lithium Announces a 7,500 Metre Winter Drill Program on Its Zoro Lithium Property
XOMAO

GlobeNewswire

a year ago

Foremost Lithium Announces a 7,500 Metre Winter Drill Program on Its Zoro Lithium Property

XOMA Declares Quarterly Preferred Stock Dividends
XOMAO

GlobeNewswire

a year ago

XOMA Declares Quarterly Preferred Stock Dividends

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting
XOMAO

GlobeNewswire

a year ago

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

15 Best Falling Stocks To Buy Now
XOMAO

Insider Monkey

a year ago

15 Best Falling Stocks To Buy Now

XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties
XOMAO

GlobeNewswire

a year ago

XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties

Medigus: Jeffs' Brands Signs a Non-Binding Letter of Intent to acquire a 70% in a Laser-based Technology Company Developing Defense Solutions Against Drone-based Visual Systems
XOMAO

GlobeNewswire

a year ago

Medigus: Jeffs' Brands Signs a Non-Binding Letter of Intent to acquire a 70% in a Laser-based Technology Company Developing Defense Solutions Against Drone-based Visual Systems

Implied Volatility Surging for On Kingstone (KINS) Stock Options
XOMAO

Zacks

a year ago

Implied Volatility Surging for On Kingstone (KINS) Stock Options

Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin's Late-Stage Development and Commercialization
XOMAO

PR Newswire

a year ago

Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin's Late-Stage Development and Commercialization

XOMAO

GlobeNewswire

a year ago

180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives

XOMAO

GlobeNewswire

2 years ago

Society Pass Inc (Nasdaq: SOPA) / NusaTrip Inc Partners with Vietnam-based Travel Platform, VN Travel Group, to Jointly Market to Vietnamese Customers

XOMAO

GlobeNewswire

2 years ago

180 Life Sciences Announces Review of Strategic Alternatives

XOMAO

GlobeNewswire

2 years ago

Society Pass Inc (Nasdaq: SOPA) Granted Extension until 20 May 2024 to Regain Compliance with Nasdaq Listing Rules

XOMAO

GlobeNewswire

2 years ago

Society Pass Inc (Nasdaq: SOPA): Maxim Issues 3Q 2023 Equity Research Update; Maintains Positive Outlook on Organic Growth & M&A

XOMAO

GlobeNewswire

2 years ago

Onfolio Launches Off-Market Deal Origination Service DealPipe

XOMAO

GlobeNewswire

2 years ago

Onfolio Subsidiary Vital Reaction Completes Successful Launch Of New Pocket Inahler Product

XOMAO

GlobeNewswire

2 years ago

Onfolio Web 3 Subsidiary Achieves First Profitable Month

Splash Beverage Group Reports Third Quarter 2023 Financial Results, Quarterly Revenues Rise 5%, Nine Month Revenues Rise 22%
XOMAO

GlobeNewswire

2 years ago

Splash Beverage Group Reports Third Quarter 2023 Financial Results, Quarterly Revenues Rise 5%, Nine Month Revenues Rise 22%

Share on Social Networks: